Two samples harbored a pathogenic variant in CHEK2, one with LOH of the wild-type allele, classified as HRP (BC-53) and one with unknown LOH status of the wild-type allele that was classified as HRD (BC-36). Here, CHEK2 is linked to breast cancer.